Revolutionizing pediatric cardiac care: the hope of Intellistent

Heartpoint’s IntelliStent system is designed to use minimally invasive catheter delivery to place adjustable stents that adjust blood flow in the pulmonary arteries. [Illustration courtesy of Heartpoint]

By Seth Bogner, HeartPoint Global

In pediatric cardiology, a persistent challenge revolves around ensuring accessible and effective care for children grappling with congenital heart disease (CHD). CHD affects approximately 1.7% of newborns globally, or 2.4 million, of which 90% have the urgent need for affordable and specialized treatments that call for innovative solutions.

According to a recent article in The Journal of the American College of Cardiology (JACC), economic constraints in many developing nations contribute to delayed diagnosis and treatment for up to 90% of children with CHD, leading to severe consequences such as organ dysfunction and complications like profound cyanosis and polycy…

Read more
  • 0

How Heartpoint designed its TCT Shark Tank-winning IntelliStent system

Heartpoint’s IntelliStent system is designed to use minimally invasive catheter delivery to place adjustable stents that adjust blood flow in the pulmonary arteries. [Illustration courtesy of Heartpoint]

Heartpoint Global is developing a device to adjust pulmonary blood flow in infants born with congenital heart disease, avoiding risky pulmonary artery banding.

The Coral Gables, Florida–based startup recently won the Transcatheter Cardiovascular Therapeutics (TCT) conference’s Shark Tank Innovation Competition and is now preparing to submit its technology to the FDA for breakthrough device designation.

Heartpoint Global designed its multi-lumen IntelliStent system to restrict the blood flow in the arteries between the heart and lungs. The system can also allow a physician to later adjust the patient’s blood flow as they grow or their condition changes.

The system includes self-ex…

Read more
  • 0